About
Dan Becker joined New Leaf Venture Partners in 2015. Prior to joining New Leaf, Dan was a Principal at the Boston Consulting Group where he was a core member of their Health Care practice and led projects across the health care sector with an emphasis on biopharma R&D. Prior to BCG, Dan was a Research Fellow at Harvard Medical School, and trained clinically in internal medicine and nephrology at Brigham and Women’s Hospital and Massachusetts General Hospital. Dan graduated summa cum laude with a B.S. in Physiology from the University of Illinois at Urbana-Champaign, and obtained both his M.D. and Ph.D. (Cellular and Molecular Biology) degrees from the University of Michigan. Dan has co-authored multiple scientific publications in peer-reviewed journals, including Nature Genetics and the Journal of Cell Biology. He is Board-certified in Internal Medicine.
Position in the VCSift Database
- • 2 investors at Access Biotechnology are tracked.
- • 658 investors hold the Principal role in VCSift. Dan Becker is one of them.
- • 206 investors are based in San Mateo, California, United States.
Data sourced from 410,343 investor profiles. Updated June 2026.
Investment Focus
- Location
- San Mateo, US
Contact Information
Find more investors like Dan
Search Investors